181951-92-8 Usage
Uses
Used in Pharmaceutical Industry:
FMOC-4-(TERT-BUTOXYCARBONYLMETHOXY)-L-PHENYLALANINE is used as a key component in the synthesis of peptides for various pharmaceutical applications. Its role is crucial for the development of new drugs and therapeutic agents, given its ability to facilitate the creation of stable and effective peptide-based compounds.
Used in Research Applications:
In the research field, FMOC-4-(TERT-BUTOXYCARBONYLMETHOXY)-L-PHENYLALANINE is used as a fundamental building block for the synthesis of peptides that are essential for scientific studies. It aids researchers in exploring the properties and potential applications of peptides, contributing to advancements in biotechnology and medicine.
Used in Peptide Synthesis:
FMOC-4-(TERT-BUTOXYCARBONYLMETHOXY)-L-PHENYLALANINE is used as a protected amino acid in peptide synthesis. The presence of the FMOC and Boc protecting groups allows for the controlled addition of phenylalanine to growing peptide chains, ensuring the desired peptide sequence is achieved without premature termination or side reactions. This makes it an indispensable tool in the solid-phase peptide synthesis process.
Check Digit Verification of cas no
The CAS Registry Mumber 181951-92-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,1,9,5 and 1 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 181951-92:
(8*1)+(7*8)+(6*1)+(5*9)+(4*5)+(3*1)+(2*9)+(1*2)=158
158 % 10 = 8
So 181951-92-8 is a valid CAS Registry Number.
181951-92-8Relevant articles and documents
Enantioselective synthesis of nonphosphorus-containing phosphotyrosyl mimetics and their use in the preparation of tyrosine phosphatase inhibitory peptides
Burke Jr., Terrence R.,Yao, Zhu-Jun,Zhao, He,Milne, George W. A.,Wu, Li,Zhang, Zhong-Yin,Voigt, Johannes H.
, p. 9981 - 9994 (2007/10/03)
Three new L-amino acid analogues 12, 18 and 25 have been prepared in protected form suitable for incorporation into peptides by solid-phase synthesis using Fmoc protocols. These agents represent nonphosphorus- containing phosphotyrosyl (pTyr) mimetics, wh